129 related articles for article (PubMed ID: 34570616)
1. Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children.
Keilty D; Khandwala M; Liu ZA; Papaioannou V; Bouffet E; Hodgson D; Yee R; Cushing S; Laperriere N; Ahmed S; Mabbott D; Ramaswamy V; Tabori U; Huang A; Bartels U; Tsang DS
J Clin Oncol; 2021 Dec; 39(34):3813-3821. PubMed ID: 34570616
[TBL] [Abstract][Full Text] [Related]
2. Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.
Murphy B; Jackson A; Bass JK; Tsang DS; Ronckers CM; Kremer L; Baliga S; Olch A; Zureick AH; Jee KW; Constine LS; Yock TI
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):446-456. PubMed ID: 37855793
[TBL] [Abstract][Full Text] [Related]
3. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
4. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy.
Cohen-Cutler S; Wong K; Mena V; Sianto K; Wright MA; Olch A; Orgel E
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1488-1495. PubMed ID: 33677052
[TBL] [Abstract][Full Text] [Related]
5. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.
Hua C; Bass JK; Khan R; Kun LE; Merchant TE
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):892-9. PubMed ID: 18395355
[TBL] [Abstract][Full Text] [Related]
6. Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer-A prospective study.
Apoorva KV; Vijendra Shenoy S; Athiyamaan MS; Kabekkodu S; Kshithi K; Zuturu N
Am J Otolaryngol; 2023; 44(4):103914. PubMed ID: 37178536
[TBL] [Abstract][Full Text] [Related]
7. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the GSTP1 c.313A>G variant to hearing loss risk in patients exposed to platin chemotherapy during childhood.
Liberman PHP; Goffi-Gomez MVS; Schultz C; Jacob PL; de Paula CAA; Sartorato EL; Torrezan GT; Ferreira EN; Carraro DM
Clin Transl Oncol; 2019 May; 21(5):630-635. PubMed ID: 30361796
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
[TBL] [Abstract][Full Text] [Related]
10. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
Dean JB; Hayashi SS; Albert CM; King AA; Karzon R; Hayashi RJ
J Pediatr Hematol Oncol; 2008 Feb; 30(2):130-4. PubMed ID: 18376265
[TBL] [Abstract][Full Text] [Related]
11. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors.
Funt SA; Knezevic A; Wilson K; Bromberg M; Budnick A; O'Connor KL; McHugh DJ; Larsen E; Bajorin DF; Motzer RJ; Tonorezos ES; Patil S; Feldman DR
Cancer; 2023 Dec; 129(24):3952-3961. PubMed ID: 37715631
[TBL] [Abstract][Full Text] [Related]
13. The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
Scobioala S; Parfitt R; Matulat P; Byrne J; Langer T; Troschel FM; Hesping AE; Clemens E; Kaatsch P; Grabow D; Kaiser M; Spix C; Kremer LC; Calaminus G; Baust K; Kuehni CE; Weiss A; Strebel S; Kuonen R; Elsner S; Haupt R; Garré ML; Gruhn B; Kepak T; Kepakova K; Winther JF; Kenborg L; Rechnitzer C; Hasle H; Kruseova J; Luks A; Lackner H; Bielack S; Beck JD; Jürgens H; van den Heuvel-Eibrink MM; Zolk O; Eich HT; Am Zehnhoff-Dinnesen A;
Int J Cancer; 2024 Jan; 154(2):320-331. PubMed ID: 37715472
[TBL] [Abstract][Full Text] [Related]
14. The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer.
Caballero M; Mackers P; Reig O; Buxo E; Navarrete P; Blanch JL; Grau JJ
Oncology; 2017; 93(2):75-82. PubMed ID: 28511189
[TBL] [Abstract][Full Text] [Related]
15. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
Deutsch BC; Collopy C; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2021 Feb; 147(2):182-189. PubMed ID: 33300954
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
[TBL] [Abstract][Full Text] [Related]
17. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
18. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
Waissbluth S; Del Valle Á; Chuang A; Becker A
Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.
Sanchez VA; Dinh PC; Monahan PO; Althouse S; Rooker J; Sesso HD; Dolan ME; Weinzerl M; Feldman DR; Fung C; Einhorn LH; Frisina RD; Travis LB
JAMA Oncol; 2024 Jun; ():. PubMed ID: 38842797
[TBL] [Abstract][Full Text] [Related]
20. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
